Peptide T TFA is primarily used in research focused on understanding and treating conditions related to the central nervous system and immune function. It has been studied for its potential role in managing symptoms associated with HIV/AIDS, particularly in addressing neurological complications. Researchers explore its ability to interact with specific receptors in the brain, which may help mitigate cognitive decline and improve overall neurological health. Additionally, it is investigated for its anti-inflammatory properties, which could be beneficial in treating autoimmune disorders and chronic inflammatory conditions. Its application in experimental therapies highlights its potential in advancing medical treatments for complex diseases.